-
Mashup Score: 0Genomic testing in prostate cancer - 3 year(s) ago
Emmanuel Seront, MD, PhD, Jolimont Hospital, La Louvière, Belgium, outlines the use of genomic testing in prostate cancer as well…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Second-line treatment of mHSPC - 3 year(s) ago
Ursula Vogl, MD, Ente Ospedaliero Cantonale (EOC), Ticino, Switzerland, explores the difficulties of sequencing second-line therapies for metastatic hormone-sensitive prostate…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Immunotherapy in prostate cancer - 3 year(s) ago
Emmanuel Seront, MD, PhD, Jolimont Hospital, La Louvière, Belgium, discusses the use of immunotherapies in prostate cancer including ongoing studies…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Unmet needs in mHSPC - 3 year(s) ago
Ursula Vogl, MD, Ente Ospedaliero Cantonale (EOC), Ticino, Switzerland, outlines areas of unmet need in metastatic hormone-sensitive prostate cancer (mHSPC)…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Unmet need in bladder cancer - 3 year(s) ago
Arlene Siefker-Radtke, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines some areas of unmet needs in…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Improving precision of high-quality prostate cancer MRI - 3 year(s) ago
Anwar Padhani, MBBS, FRCP, FRCR, Paul Strickland Scanner Centre Mount Vernon Cancer Centre, Northwood, UK, outlines approaches to improve the…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0NMIBC: new approaches - 3 year(s) ago
Amir Mostafid, MSc, FRCS, FEBU, Royal Surrey County Hospital, Guildford, Surrey, UK, discusses new approaches in treating non-muscle invasive bladder…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Advances in non-metastatic castration-resistant prostate cancer - 4 year(s) ago
Emmanuel Seront, MD, PhD, Jolimont Hospital, La Louvière, Belgium, reviews advances in non-metastatic castration-resistant prostate cancer as well as agents…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Challenges and treatment advances in mHSPC - 4 year(s) ago
Ursula Vogl, MD, Ente Ospedaliero Cantonale (EOC), Ticino, Switzerland, discusses treatment advances in metastatic hormone-sensitive prostate cancer (mHSPC) as well…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing? - 4 year(s) ago
Arlene Siefker-Radtke, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses efforts being made to optimize the…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
VIDEO: Genomic testing in #ProstateCancer w/ Emmanuel Seront of @GroupeJolimont: https://t.co/8476bixare @VJOncology @OncoAlert #PROSCA2020 #BLADDR2020 #PCsm #OncoAlert